This disclosure is directed to a method of treating dependency on an opioid drug, including acute and post-acute withdrawal symptoms, comprising treating an opioid-dependent patient with noribogaine, noribogaine derivative, or pharmaceutically acceptable salt or solvate thereof with a multi-dose regimen and optionally an opioid antagonist.